Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P070001/S031

prodisc C Nova

Centinel Spine, LLC · Decision date Sep 9, 2026

FDA DECISIONP070001/S031

What did the FDA approve?

FDA records P070001/S031 as a supplement to PMA P070001, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Sep 9, 2026.

FDA approval order statement

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) 180-day supplement, which requested approval for the prodisc C Nova requesting expansion of the indications from one-level use to two-level use.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Orthopedic
Decision date
Sep 9, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P070001/S031
Regulatory pathway
PMA supplement
Product code
MJO
Decision code
APPR
Decision date
Sep 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

For the original device and its historical approval scope, see PMA P070001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P070001 · Original PMA

    PRODISC TM-C TOTAL DISC REPLACEMENT

  2. P070001/S031 received

    Application receipt date recorded by FDA.

  3. P070001/S031 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P070001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070001

Product / regulatory recordCompanyPathwayDecision dateSource
Centinel Spine, LLCPMA approvalDec 17, 2007FDA

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Synergy DiscP250028/S003
Synergy Spine Solutions, Inc.PMA supplementSep 17, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
Spineart USA, Inc.PMA approvalAug 10, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Centinel Spine, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
900 Airport Rd., Suite 3b, West Chester, PA, 19380

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records